Home › Opioid Overdose › NCT06458985

Disclosure Intervention for People in Treatment for Opioid Use Disorder

Disclosure Intervention to Reduce Social Isolation and Facilitate Recovery Among People in Treatment for Opioid Use Disorder

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Client of Brandywine Counseling \& Community Services
* Receiving opioid use disorder treatment at Brandywine Counseling \& Community Services
* Considering disclosing one's opioid use disorder history and/or treatment to someone new

Exclusion Criteria:

* Diagnosis of schizophrenia
* Participation in pilot study of intervention

About the study

The goal of this clinical trial is to test a disclosure intervention among people in treatment for opioid use disorder. The main question it aims to answer is whether people who receive a disclosure intervention have better treatment- and recovery-related outcomes one year after receiving the intervention. Participants will complete a brief disclosure intervention designed to help them (1) make key disclosures related to disclosure and (2) build skills to disclose. Researchers will compare results to participants in a waitlist comparator condition, who receive the intervention at the end of the study.

What is being tested

• Disclosing Recovery: A Decision Aid and Toolkit (behavioral)

Sponsor: University of Delaware · Participants: 480 · Started: May 20, 2024

Contact the study team

• Valerie A Earnshaw, PhD · Phone: 1-302-831-4772

Official record on ClinicalTrials.gov — NCT06458985

Locations in the U.S.

Conditions

• Opioid Overdose
• Social Isolation
• Social Stigma

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.